Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xenon Pharmaceuticals granted 20,200 share options and 11,850 restricted share units to four new non-officer employees as employment inducements. The options have an exercise price of $60.30, equal to the closing price on the grant date, and vest over four years with a one-year cliff.
Key figures
- Rsus granted
- 11850
- Exercise price
- 60.3
- Options granted
- 20200
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.